The story of Viagra and the pharmaceutical industry presents a challenging picture for prospective investors. Initially, copyright's remarkable drug altered the treatment of erectile dysfunction, generating significant profits and defining the current pharmaceutical landscape. However, intellectual property expiration and the rise of alternative ve